Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A 2024 inventory in oncology news].
Vignot S, Bellesoeur A, Bouleuc C, Cohen R, Courtier B, Crozier C, De Nonneville A, Delom F, Evrard S, Firmin N, Gandemer V, Khettab M, Magné N, Orbach D, Pellier I, Rodrigues M, Wislez M, Bay JO. Vignot S, et al. Among authors: de nonneville a. Bull Cancer. 2025 Jan;112(1):19-34. doi: 10.1016/j.bulcan.2024.12.001. Epub 2024 Dec 16. Bull Cancer. 2025. PMID: 39690092 Free article. Review. French.
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy.
Bertucci F, Guille A, Lerebours F, Ceccarelli M, Syed N, Adélaïde J, Finetti P, Ueno NT, Van Laere S, Viens P, De Nonneville A, Goncalves A, Birnbaum D, Callens C, Bedognetti D, Mamessier E. Bertucci F, et al. Among authors: de nonneville a. J Transl Med. 2024 Oct 27;22(1):969. doi: 10.1186/s12967-024-05790-8. J Transl Med. 2024. PMID: 39465437 Free PMC article.
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.
Houvenaeghel G, Classe JM, Chauvet MP, Colombo PE, Jouve E, Reyal F, Daraï E, Rouzier R, Faure-Virelizier C, Gimbergues P, Coutant C, Mazouni C, Azuar AS, Martino M, Bouteille C, Cohen M, de Nonneville A. Houvenaeghel G, et al. Among authors: de nonneville a. Cancers (Basel). 2024 Sep 27;16(19):3317. doi: 10.3390/cancers16193317. Cancers (Basel). 2024. PMID: 39409937 Free PMC article.
Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases.
Houvenaeghel G, Heinemann M, Classe JM, Bouteille C, Gimbergues P, Azuar AS, Martino M, Tallet A, Cohen M, de Nonneville A. Houvenaeghel G, et al. Among authors: de nonneville a. Cancers (Basel). 2024 Jul 26;16(15):2666. doi: 10.3390/cancers16152666. Cancers (Basel). 2024. PMID: 39123393 Free PMC article.
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization.
de Nonneville A, Kalbacher E, Cannone F, Guille A, Adelaïde J, Finetti P, Cappiello M, Lambaudie E, Ettore G, Charafe E, Mamessier E, Provansal M, Bertucci F, Sabatier R. de Nonneville A, et al. Mol Oncol. 2024 Oct;18(10):2586-2600. doi: 10.1002/1878-0261.13679. Epub 2024 Jun 25. Mol Oncol. 2024. PMID: 38923749 Free PMC article.
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.
Poumeaud F, Morisseau M, Cabel L, Gonçalves A, Rivier C, Trédan O, Volant E, Frenel JS, Ladoire S, Jacot W, Jamelot M, Foka Tichoue H, Patsouris A, Teixeira L, Bidard FC, Loirat D, Brunet M, Levy C, Bailleux C, Cabarrou B, Deleuze A, Uwer L, Deluche E, Grellety T, Franchet C, Fiteni F, Bischoff H, Vion R, Pagliuca M, Verret B, Bécourt S, Reverdy T, de Nonneville A, Dalenc F. Poumeaud F, et al. Among authors: de nonneville a. Br J Cancer. 2024 Sep;131(4):702-708. doi: 10.1038/s41416-024-02766-9. Epub 2024 Jun 25. Br J Cancer. 2024. PMID: 38918555
70 results